Plus
Inside Trump’s $50B Pharma Deal with AstraZeneca
New deal to slash drug prices under his “Most Favored Nation” plan.
Both promise lower prices for Medicaid and new meds.
Buy meds direct from drugmakers — up to 80% off for chronic illnesses.
AstraZeneca investing $50B in U.S. manufacturing, incl. a $4.5B Virginia plant.
Drug giants get a 3-year tariff break for joining the plan.
Experts call the numbers “unclear” — some even “impossible.”
U.S. may pay less, but other countries could pay more.
Big promise — real savings still TBD.
Dashed Trail
Liked this story?
Click to explo
Next
Top 10 Most Fuel-Efficient Hybrids in America
Share it
Share
Next Story